Hyaluronic acid reverses the abnormal synthetic activity of human osteoarthritic subchondral bone osteoblasts

Bone

Volumn 33, Issue 4, 2003, Pages 703-710

  Lajeunesse, Daniel ^a,b   Delalandre, Aline ^a   Martel Pelletier, Johanne ^a   Pelletier, Jean Pierre ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOLOGICAL MARKER; CALCITRIOL; CYCLIC AMP; HYALURONIC ACID; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROSTAGLANDIN E2; SOMATOMEDIN C; UROKINASE;

ADULT; AGED; ARTICLE; BONE METABOLISM; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; MALE; MOLECULAR WEIGHT; OSTEOARTHRITIS; OSTEOBLAST; PROTEIN EXPRESSION;

EID: 0141638631     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(03)00206-0     Document Type: Article

References (39)

1. Pelletier J.P., Martel-Pelletier J., Howell D.S. Etiopathogenesis of osteoarthritis. Koopman W.J. Arthritis & allied conditions. A textbook of rheumatology. 14th ed: 2001;2195-2245 Williams & Wilkins, Baltimore.
2. Hilal G., Martel-Pelletier J., Pelletier J.P., Ranger P., Lajeunesse D. Osteoblast-like cells from human subchondral osteoarthritic bone demonstrate an altered phenotype in vitro possible role in subchondral bone sclerosis . Arthritis Rheum. 41:1998;891-899.
3. Dequeker J., Mohan R., Finkelman R.D., Aerssens J., Baylink D.J. Generalized osteoarthritis associated with increased insulin-like growth factor types I and II and transforming growth factor beta in cortical bone from the iliac crest. Possible mechanism of increased bone density and protection against osteoporosis. Arthritis Rheum. 36:1993;1702-1708.
4. Mansell J.P., Bailey A.J. Abnormal cancellous bone collagen metabolism in osteoarthritis. J Clin Invest. 101:1998;1596-1603.
5. Mansell J.P., Tarlton J.F., Bailey A.J. Biochemical evidence for altered subchondral bone collagen metabolism in osteoarthritis of the hip. Br J Rheumatol. 36:1997;16-19.
6. Hilal G., Martel-Pelletier J., Pelletier J.P., Duval N., Lajeunesse D. Abnormal regulation of urokinase plasminogen activator by insulin-like growth factor 1 in human osteoarthritic subchondral osteoblasts. Arthritis Rheum. 42:1999;2112-2122.
7. Genever P.G., Dickson I.R. Influence of vitamin D status on hyaluronan localization in bone. Bone. 18:1996;429-435.
8. Klokkevold P.R., Vandemark L., Kenney E.B., Bernard G.W. Osteogenesis enhanced by chitosan (poly-N-acetyl glucosaminoglycan) in vitro. J Periodontol. 67:1996;1170-1175.
9. Sasaki T., Watanabe C. Stimulation of osteoinduction in bone wound healing by high-molecular hyaluronic acid. Bone. 16:1995;9-15.
10. Midura R.J., Evanko S.P., Hascall V.C. Parathyroid hormone stimulates hyaluronan synthesis in an osteoblast-like cell line. J Biol Chem. 269:1994;13200-13206.
11. Jacob A., Faddis B.T., Chole R.A. MeroGel hyaluronic acid sinonasal implants osteogenic implications . Laryngoscope. 112:2002;37-42.
12. Altman R.D. Osteoarthritis. Aggravating factors and therapeutic measures. Postgrad Med. 80:1986;150-163.
13. Smith P.K., Krohn R.I., Hermanson G.T., Mallia A.K., Gartner F.H., Provenzano M.D., et al. Measurement of protein using bicinchoninic acid. Anal Biochem. 150:1985;76-85.
14. Leprince P., Rogister B., Moonen G. A colorimetric assay for the simultaneous measurement of plasminogen activators and plasminogen activator inhibitors in serum-free conditioned media from cultured cells. Anal Biochem. 177:1989;341-346.
15. 2 by isolated human subchondral osteoblasts identify two subgroups of osteoarthritic patients. Osteoarthritis Cartilage. 10:2002;491-500.
16. Rydell N., Balazs E.A. Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthop. 80:1971;25-32.
17. Fraser J.R., Kimpton W.G., Pierscionek B.K., Cahill R.N. The kinetics of hyaluronan in normal and acutely inflamed synovial joints observations with experimental arthritis in sheep . Semin Arthritis Rheum. 22:1993;9-17.
18. Laurent U.B., Fraser J.R., Engstrom-Laurent A., Reed R.K., Dahl L.B., Laurent T.C. Catabolism of hyaluronan in the knee joint of the rabbit. Matrix. 12:1992;130-136.
19. Ghosh P., Guidolin D. Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis are the effects molecular weight dependent? Semin Arthritis Rheum. 32:2002;10-37.
20. 2 induction by interleukin-1 in rabbit articular chondrocytes. Agents Actions. 38:1993;122-125.
21. 2 production in human osteoarthritic synovial cells. Agents Actions. 37:1992;155-156.
22. Fukuda K., Dan H., Takayama M., Kumano F., Saitoh M., Tanaka S. Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J Pharmacol Exp Ther. 277:1996;1672-1675.
23. Lisignoli G., Grassi F., Piacentini A., Cocchini B., Remiddi G., Bevilacqua C., et al. Hyaluronan does not affect cytokine and chemokine expression in osteoarthritic chondrocytes and synoviocytes. Osteoarthritis Cartilage. 9:2001;161-168.
24. Cho B.C., Park J.W., Baik B.S., Kwon I.C., Kim I.S. The role of hyaluronic acid, chitosan, and calcium sulfate and their combined effect on early bony consolidation in distraction osteogenesis of a canine model. J Craniofac Surg. 13:2002;783-793.
25. Lisignoli G., Fini M., Giavaresi G., Nicoli A.N., Toneguzzi S., Facchini A. Osteogenesis of large segmental radius defects enhanced by basic fibroblast growth factor activated bone marrow stromal cells grown on non-woven hyaluronic acid-based polymer scaffold. Biomaterials. 23:2002;1043-1051.
26. Foss M.V.L., Byers P.D. Bone density, osteoarthrosis of the hip and fracture of the upper end of the femur. Ann Rheum Dis. 31:1972;259-264.
27. Roh Y.S., Dequeker J., Muiler J.C. Bone mass is osteoarthrosis, measured in vivo by photon absorption. J Bone Joint Surg Am. 54A:1974;587-591.
28. Grynpas M.D., Alpert B., Katz I., Lieberman I., Pritzker K.P.H. Subchondral bone in osteoarthritis. Calcif Tissue Int. 49:1991;20-26.
29. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature. 382:1996;448-452.
30. Hausler G., Helmreich M., Marlovits S., Egerbacher M. Integrins and extracellular matrix proteins in the human childhood and adolescent growth plate. Calcif Tissue Int. 71:2002;212-218.
31. Kaartinen M.T., EI-Maadawy S., Rasanen N.H., McKee M.D. Tissue transglutaminase and its substrates in bone. J Bone Miner Res. 17:2002;2161-2173.
32. 2 and insulin-like growth factor 1 can modulate the levels of parathyroid hormone receptor in human osteoarthritic osteoblasts. J Bone Miner Res. 16:2001;713-721.
33. Civitelli R., Hruska K.A., Shen V., Avioli L.V. Cyclic AMP-dependent and calcium-dependent signals in parathyroid hormone function. Exp Gerontol. 25:1990;223-231.
34. Partridge N.C., Bloch S.R., Pearman A.T. Signal transduction pathways mediating parathyroid hormone regulation of osteoblastic gene expression. J Cell Biochem. 55:1994;321-327.
35. Bettica P., Cline G., Hart D.J., Meyer J., Spector T.D. Evidence for increased bone resorption in patients with progressive knee osteoarthritis longitudinal results from the Chingford study . Arthritis Rheum. 46:2002;3178-3184.
36. Seibel M.J., Duncan A., Robins S.P. Urinary hydroxy-pyridinium crosslinks provide indices of cartilage and bone involvement in arthritic diseases. J Rheumatol. 16:1989;964-970.
37. Ledger G.A., Burritt M.F., Kao P.C., O'Fallon W.M., Riggs B.L., Khosla S. Role of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption. J Clin Endocrinol Metab. 80:1995;3304-3310.
38. 2 genaration and prostaglandin E-2-elicited cyclic AMP accumulation in human rheumatoid arthritic synovial cells. Jp J Rheumatol. 5:1994;227-236.
39. 2 in fetal rat osteoblasts role of protein kinase A signaling pathway . J Bone Miner Res. 13:1998;1092-1100.